309 related articles for article (PubMed ID: 24476011)
21. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
United European Gastroenterol J; 2020 Apr; 8(3):321-331. PubMed ID: 32213023
[TBL] [Abstract][Full Text] [Related]
22. Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy.
Yilmaz Y; Yesil A; Gerin F; Ergelen R; Akin H; Celikel ÇA; Imeryuz N
Scand J Gastroenterol; 2014 May; 49(5):611-6. PubMed ID: 24611771
[TBL] [Abstract][Full Text] [Related]
23. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.
Petroff D; Blank V; Newsome PN; Shalimar ; Voican CS; Thiele M; de Lédinghen V; Baumeler S; Chan WK; Perlemuter G; Cardoso AC; Aggarwal S; Sasso M; Eddowes PJ; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Cobbold JF; Naveau S; Lupsor-Platon M; Mueller S; Krag A; Irles-Depe M; Semela D; Wong GL; Wong VW; Villela-Nogueira CA; Garg H; Chazouillères O; Wiegand J; Karlas T
Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):185-198. PubMed ID: 33460567
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.
Tavaglione F; De Vincentis A; Bruni V; Gallo IF; Carotti S; Tuccinardi D; Spagnolo G; Ciociola E; Mancina RM; Jamialahmadi O; D'Alessio R; Bottazzi B; Manfrini S; Picardi A; Perrone G; Pozzilli P; Caricato M; Vespasiani-Gentilucci U; Romeo S
Liver Int; 2022 Feb; 42(2):374-383. PubMed ID: 34890093
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B.
Wang CY; Lu W; Hu DS; Wang GD; Cheng XJ
World J Gastroenterol; 2014 Aug; 20(30):10585-90. PubMed ID: 25132779
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Pu K; Wang Y; Bai S; Wei H; Zhou Y; Fan J; Qiao L
BMC Gastroenterol; 2019 Apr; 19(1):51. PubMed ID: 30961539
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound and FibroScan
Salmi A; di Filippo L; Ferrari C; Frara S; Giustina A
Endocrine; 2022 Nov; 78(2):262-269. PubMed ID: 35980569
[TBL] [Abstract][Full Text] [Related]
28. [Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan].
Xu L; Li P; Lu W; Shi Q; Shi R; Zhang X; Liu Y; Wang Q; Fan J; Mi Y
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):108-13. PubMed ID: 26983477
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of the controlled attenuation parameter for detecting liver steatosis in health checkup examinees.
Kim JK; Lee KS; Choi JR; Chung HJ; Jung DH; Lee KA; Lee JI
Gut Liver; 2015 May; 9(3):405-10. PubMed ID: 25717046
[TBL] [Abstract][Full Text] [Related]
30. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
[TBL] [Abstract][Full Text] [Related]
31. Controlled attenuation parameter for the detection of hepatic steatosis in patients with chronic hepatitis B.
Chen J; Wu D; Wang M; Chen E; Bai L; Liu C; Liao J; Tang H
Infect Dis (Lond); 2016 Sep; 48(9):670-5. PubMed ID: 27241724
[TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
Hong YM; Yoon KT; Cho M; Chu CW; Rhu JH; Yang KH; Lee JW
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.
Cardoso AC; Beaugrand M; de Ledinghen V; Douvin C; Poupon R; Trinchet JC; Ziol M; Bedossa P; Marcellin P
Ann Hepatol; 2015; 14(6):826-36. PubMed ID: 26436354
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Cao YT; Xiang LL; Qi F; Zhang YJ; Chen Y; Zhou XQ
EClinicalMedicine; 2022 Sep; 51():101547. PubMed ID: 35844772
[TBL] [Abstract][Full Text] [Related]
35. The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.
Fujiwara Y; Kuroda H; Abe T; Ishida K; Oguri T; Noguchi S; Sugai T; Kamiyama N; Takikawa Y
Ultrasound Med Biol; 2018 Nov; 44(11):2223-2232. PubMed ID: 30077415
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease.
Jung KS; Kim BK; Kim SU; Chon YE; Chun KH; Kim SB; Lee SH; Ahn SS; Park JY; Kim DY; Ahn SH; Park YN; Han KH
PLoS One; 2014; 9(6):e98689. PubMed ID: 24901649
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of B-mode ultrasound-based attenuation for the diagnosis of hepatic steatosis: a systematic review/meta-analysis.
Hirooka M; Koizumi Y; Sunago K; Nakamura Y; Hirooka K; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
J Med Ultrason (2001); 2022 Apr; 49(2):199-210. PubMed ID: 35239088
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
Jang JK; Kim SY; Yoo IW; Cho YB; Kang HJ; Lee DH
Eur Radiol; 2022 Mar; 32(3):2070-2077. PubMed ID: 34549325
[TBL] [Abstract][Full Text] [Related]
39. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience.
Baumeler S; Jochum W; Neuweiler J; Bergamin I; Semela D
Swiss Med Wkly; 2019 Apr; 149():w20077. PubMed ID: 31026041
[TBL] [Abstract][Full Text] [Related]
40. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
Semmler G; Stift J; Scheiner B; Wöran K; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Pinter M; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M
Dig Dis Sci; 2019 Dec; 64(12):3642-3651. PubMed ID: 31209721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
